Biotech Investors & VC Firms in Europe
204 firms in this list, with a median first check of $540K. 19 of them lead rounds. Generated from verified public data and updated continuously.
Criteria Bio Ventures
BarcelonaSeed–Late Stage
4 people
Eyrir Venture Management
ReykjavíkSeed–Series A
4 people
NGN Capital
StamforSeries A–Late Stage
4 people
OMX Ventures
LincolnshireSeed–Series A
4 people
Rosetta Capital Ltd.
HaddenhamSeries A
4 people
Synthesis Capital
LondonSeed–Series A
4 people
MC Healthcare Ventures
New YorkSeed–Series A
2 people
Aescuvest
Frankfurt am MainSeed–Late Stage
3 people
Aravis Ventures
ZürichSeed–Late Stage
3 people
Cancer Focus
ShreveportSeries A
3 people
Good Startup
Seed–Late Stage
3 people
NATO Innovation Fund
AmsterdamSeed–Series B$16.2M
3 people
Nucleus Capital
BerlinPre-Seed–Series A
3 people
YouNick Mint
Suchy LasPre-Seed–Series A$2.7M
3 people
Bionova Capital
LisbonSeed–Series B
2 people
Cathay Health
ParisSeed–Late Stage
2 people
ePlanet Capital
San JoseSeed–Late Stage
2 people
Fresenius Medical Care Ventures
Bad HomburgSeed–Series A
2 people
Kama Flow
MoscowSeed–Late Stage
2 people
Levante Capital
BlaricumSeed–Series A
2 people
Melnichek Investments
LimassolSeed–Series A
2 people
Metaplanet
TallinnSeed–Series A
2 people
Positron Ventures
AmsterdamSeed–Series A
2 people
SCI Ventures
LondonSeed–Series A
2 people
Related lists
Crypto & Web3 Investors & VC Firms (3510)Investors & VC Firms in United States (2654)SaaS Investors & VC Firms (1994)Enterprise Software Investors & VC Firms (1791)Fintech Investors & VC Firms (1455)Healthtech Investors & VC Firms (1333)Consumer Investors & VC Firms (1247)Biotech Investors & VC Firms (1141)Data & Infrastructure Investors & VC Firms (1088)SaaS Investors & VC Firms in United States (1064)
Data sourced from public filings and firms' own websites — see our methodology.